Monday, Jun 1, 2026

"chronic-bronchitis"

  • Cipla gets USFDA nod for inhalation product

    The company has received final approval for its abbreviated new drug application (ANDA) for Arformoterol Tartrate Inhalation Solution 15 mcg/2 mL from the United States Food and Drug Administration (US FDA), Cipla said

Latest News